Ocular Surface Disease clinical trials at UCLA
1 research study open to eligible people
open to all eligible people
To evaluate glaucoma patients' response to treatment with Xiidra, an FDA-approved drug for ocular surface discomfort, which will be prescribed as standard of care treatment.
Fountain Valley, California
Our lead scientists for Ocular Surface Disease research studies include Benjamin Bert.